X0306 4 2013-12-10 0 0001031927 Echo Therapeutics, Inc. ECTE 0001339643 Nordlicht Mark C/O PLATINUM MANAGEMENT (NY) LLC 152 WEST 57TH STREET, 4TH FLOOR NEW YORK NY 10019 0 0 1 0 0001368616 Platinum Management (NY) LLC 152 WEST 57TH STREET NEW YORK NY 10019 0 0 1 0 0001120642 LANDESMAN URI C/O PLATINUM MANAGEMENT (NY) LLC 152 WEST 57TH STREET, 4TH FLOOR NEW YORK NY 10019 0 0 1 0 0001413041 Platinum Long Term Growth VII, LLC 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 0 0 1 0 0001582140 Platinum Liquid Opportunity Management (NY) LLC 152 WEST 57TH STREET 4TH FLOOR NEW YORK NY 10019 0 0 1 0 0001476165 Platinum Partners Liquid Opportunity Master Fund L.P. 152 WEST 57 STREET, 4TH FLOOR NEW YORK NY 10019 0 0 1 0 0001299265 Platinum Partners Value Arbitrage Fund, LP C/O WALKERS CORPORATE SERVICES LIMITED WALKER HOUSE, 87 MARY STREET GEORGETOWN, GRAND CAYMAN E9 KY1-9002 CAYMAN ISLANDS 0 0 1 0 0001404598 Platinum-Montaur Life Sciences, LLC 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 0 0 1 0 Common Stock 2013-12-10 4 P 0 55655 2.75 A 507824 I By Platinum Partners Value Arbitrage Fund L.P. Common Stock 2013-12-10 4 P 0 13914 2.75 A 578452 I By Platinum Partners Liquid Opportunity Master Fund L.P. Series E Preferred Stock 2013-12-10 4 P 0 1398890 2.75 A Common Stock 1398890 1398890 I By Platinum Partners Value Arbitrage Fund L.P. Series E Preferred Stock 2013-12-10 4 P 0 349723 2.75 A Common Stock 349723 349723 I By Platinum Partners Liquid Opportunity Master Fund L.P. Warrants 2.75 2013-12-10 4 P 0 1 0 A 2014-06-11 2018-12-10 Common Stock 145455 1 I By Platinum Partners Value Arbitrage Fund L.P. Warrants 2.75 2013-12-10 4 P 0 1 0 A 2014-06-11 2018-12-10 Common Stock 36363 1 I By Platinum Partners Liquid Opportunity Master Fund L.P. This Form 4 is filed jointly by Platinum Partners Value Arbitrage Fund L.P. ("PPVA"), Platinum Partners Liquid Opportunity Master Fund L.P. ("PPLO"), Platinum Long Term Growth VII, LLC ("Platinum VII"), Platinum-Montaur Life Sciences, LLC ("Platinum-Montaur"), Platinum Management (NY) LLC ("Platinum Management"), Platinum Liquid Opportunity Management (NY) LLC ("Platinum Liquid Management"), Mark Nordlicht and Uri Landesman (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein. Securities owned directly by PPVA. Each of Platinum Management, as the Investment Manager of PPVA, and Mark Nordlicht and Uri Landesman, as the Chief Investment Officer and President, respectively, of Platinum Management, may be deemed to beneficially own the securities owned directly by PPVA. Securities owned directly by PPLO. Each of Platinum Liquid Management, as the Investment Manager of PPLO and Mark Nordlicht and Uri Landesman, as the Chief Investment Officer and President, respectively, of Platinum Liquid Management, may be deemed to beneficially own the securities owned directly by PPLO. The shares of Series E Preferred Stock (the "Preferred Stock") are immediately exercisable. Pursuant to the terms of the Preferred Stock, the number of shares of Common Stock that the Preferred Stock can be converted into is limited, pursuant to the terms of the Preferred Stock, to the number of shares of Common Stock to be issued pursuant to such conversion that would not exceed, when aggregated with all other shares of Common Stock owned by the holder at such time (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder ("Section 13(d)")) 19.99% of all of the Common Stock outstanding at such time (the "19.99% Preferred Stock Blocker"). The 19.99% Preferred Stock Blocker may be waived only upon (A) the holder providing the Issuer with 61 days' notice that the holder would like to waive the 19.99% Preferred Stock Blocker and (B) the stockholders of the Issuer approving the waiver of the 19.99% Preferred Stock Blocker, with regard to any or all shares of Common Stock issuable upon conversion of the Preferred Stock. The Preferred Stock also contains restrictions on conversion such that the holder may not convert the Preferred Stock if the number of shares of Common Stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of Common Stock owned by the holder at such time (as determined in accordance with Section 13(d)), in excess of 9.99% of all of the Common Stock outstanding at such time (the "9.99% Preferred Stock Blocker"). The 9.99% Preferred Stock Blocker may be waived upon the holder providing the Issuer with 61 days' notice that such holder would like to waive the 9.99% Preferred Stock Blocker. Pursuant to the terms of the Warrants, the Warrants may not be exercised if the exercise would result in the holder beneficially owning (as determined in accordance with Section 13(d)) in excess of 19.99% of all of the Common Stock outstanding at such time (the "19.99% Warrant Blocker"). The 19.99% Warrant Blocker may be waived only upon (A) the holder providing the Issuer with 61 days' notice that the holder would like to waive the 19.99% Warrant Blocker and (B) the stockholders of the Issuer approving the waiver of the 19.99% Warrant Blocker, with regard to any or all shares of Common Stock issuable upon exercise of the Warrant. Pursuant to the terms of the Warrants, the Warrants may not be exercised if the exercise would result in the holder beneficially owning (as determined in accordance with Section 13(d)) in excess of 9.99% of all of the Common Stock outstanding at such time (the "9.99% Warrant Blocker"). The 9.99% Warrant Blocker may be waived upon the holder providing the Issuer with 61 days' notice that such holder would like to waive the 9.99% Warrant Blocker. /s/ Mark Nordlicht 2013-12-12 Platinum Partners Value Arbitrage Fund L.P., By Platinum Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer 2013-12-12 Platinum Partners Liquid Opportunity Master Fund L.P., By Platinum Liquid Opportunity Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer 2013-12-12 Platinum Long Term Growth VII, LLC, By Platinum Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer 2013-12-12 Platinum-Montaur Life Sciences, LLC, By Platinum Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer 2013-12-12 Platinum Management (NY) LLC, By /s/ Mark Nordlicht, Chief Investment Officer 2013-12-12 Platinum Liquid Opportunity Management (NY) LLC, By /s/ Mark Nordlicht, Chief Investment Officer 2013-12-12 /s/ Uri Landesman 2013-12-12